Trials / Completed
CompletedNCT04488939
Restylane® Skinboosters™ Vital in the décolletage Region
A Prospective, Open-label Evaluation of Restylane® Skinboosters™ Vital in the décolletage Region
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Erevna Innovations Inc. · Academic / Other
- Sex
- Female
- Age
- 25 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Restylane® Skinboosters™ Vital (SBV) is a smooth formulation without particles, which helps it distribute evenly and smoothly under the skin to aid in rejuvenation. This feature makes RSV particularly well suited for more superficial injections, such as at the level of the dermis. SBV smooths fine lines and wrinkles and is intended to improve skin smoothness and appearance, as well as the elasticity and hydration of the skin in the face and dorsal hands. However, many clinicians have used SBV in other regions of the body. Given these attributes, SBV are particularly well suited for photo aged skin. A region that is susceptible to photo-ageing and may therefore benefit from the use of SBV is the décolletage. Photodamaged skin of the chest is characterized by atrophy, skin laxity, fine lines and wrinkles, dehydration and tactile roughness. Therefore, SBV may help to improve these signs of aging in the décolletage region. Study Aim: To investigate the effectiveness and tolerability of SBV for rejuvenation of the décolletage region.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane® Skinboosters™ Vital (SBV) | Hyaluronic acid |
Timeline
- Start date
- 2020-03-06
- Primary completion
- 2020-12-30
- Completion
- 2020-12-31
- First posted
- 2020-07-28
- Last updated
- 2021-02-10
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT04488939. Inclusion in this directory is not an endorsement.